Here are three key facts to know.
1. The company hopes to raise $115 million from the IPO.
2. The proceeds will be used to fund the continued commercialization of its Fuse endoscopy system, according to the report.
3. The company’s stock closed at $17.10 per share Wednesday.
More articles on gastroenterology:
Physicians Endoscopy acquires Garden State Endoscopy Center: 4 insights
CDC: CME course for colonoscopy
6 things to know about female GI physician leadership
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
